| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D411-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
| filingDate |
2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105593222-B |
| titleOfInvention |
The compound of half-life period for affinity chromatography and for extended treatment agent |
| abstract |
This application provides the compound for affinity chromatography, is more specifically for affinity chromatography with the compound of purified serum albumin (especially human serum albumins (HSA) and its fusion protein).Present invention also provides the method for the half-life period of extended treatment agent (especially therapeutic peptide reagent and small molecule), such as by the way that compound as described herein is conjugated into therapeutic peptide or small molecule (therapeutic peptide or small molecule are bound to HAS upon administration), so as to provide the extension of therapeutic agent release. |
| priorityDate |
2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |